TITLE

Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials

AUTHOR(S)
Hayden, Frederick G.; Herington, Darrell T.; Coats, Teresa L.; Kim, Kenneth; Cooper, Ellen C.; Siyu Liu; Hudson, Spencer; Pevear, Daniel C.; Collett, Marc; McKinlay, Mark
PUB. DATE
June 2003
SOURCE
Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, p1523
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The novel capsid-binding antiviral pleconaril inhibits in vitro replication of most rhinoviruses and entero-viruses. Oral pleconaril treatment was studied in 2 parallel randomized, double-blind, placebo-controlledtrials. Among 1363 picornavirus-infected participants (65%) in the studies combined, the median time to alleviation of illness was 1 day shorter for pleconaril recipients than for placebo recipients (P < .001). Cold symptom scores and frequency of picornavirus cultured from nasal mucus specimens were lower among pleconaril recipients by day 2 of treatment. No treatment effects were seen in those without picornavirus infection. Pleconaril was associated with a higher incidence of nausea (6% vs. 4%) and diarrhea (9% vs. 7%) and with small increases in mean serum cholesterol levels and platelet counts, compared with baseline measurements. A subsequent 6-week prophylaxis study found that pleconaril induces cytochrome P-450 3A enzymes, which metabolize a variety of drugs, including ethinyl estradiol. Early pleconaril treatment was well tolerated and significantly reduced the duration and severity of colds due to picornaviruses in adults.
ACCESSION #
10024029

 

Related Articles

  • The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Ramratnam, Bharat; Mittler, John E.; Zhang, Linqi; Boden, Daniel; Hurley, Arlene; Fang, Fang; Macken, Catherine A.; Perelson, Alan S.; Markowitz, Martin; Ho, David D. // Nature Medicine;Jan2000, Vol. 6 Issue 1, p82 

    Replication-competent HIV-1 can be isolated from infected patients despite prolonged plasma virus suppression by anti-retroviral treatment. Recent studies have identified resting, memory CD4[sup +] T lymphocytes as a long-lived latent reservoir of HIV-1 (refs. 4,5). Cross-sectional analyses...

  • Bovine ISG15: an antiviral and inducible protein in BIV infected fetal bovine lung cells. Chang Liu; Xin Li; Xue Yao; Xiaohong Kong; Wentao Qiao; Yunqi Geng // Virology Journal;2010, Vol. 7, p134 

    Bovine ISG15 (bISG15) is an interferon inducible ubiquitin-like protein that is responsible for the establishment of early pregnancy in ruminant, understanding the properties of bISG15 capable of being inducible in fetal bovine lung (FBL) cells upon infection of bovine immunodeficiency virus...

  • A Sialic Acid Binding Site in a Human Picornavirus. Zocher, Georg; Mistry, Nitesh; Frank, Martin; Hähnlein-Schick, Irmgard; Ekström, Jens-Ola; Arnberg, Niklas; Stehle, Thilo // PLoS Pathogens;Oct2014, Vol. 10 Issue 10, p1 

    The picornaviruses coxsackievirus A24 variant (CVA24v) and enterovirus 70 (EV70) cause continued outbreaks and pandemics of acute hemorrhagic conjunctivitis (AHC), a highly contagious eye disease against which neither vaccines nor antiviral drugs are currently available. Moreover, these viruses...

  • Antiviral Drug Discovery Targeting to Viral Proteases. Hsu, John T. A.; Hsiang-Ching Wang; Guang-Wu Chen; Shin-Ru Shih // Current Pharmaceutical Design;Apr2006, Vol. 12 Issue 11, p1301 

    Proteases fulfill multiple roles in health and disease, and considerable interest has been expressed in the design and development of synthetic inhibitors of disease-related proteases. Virus-encoded proteases have been shown to be involved in the replication of many viruses. The success of...

  • Identification of Authentic Inhibitors of HIV-1 Integration. Witvrouw, M.; Fikkert, V.; Vercammen, J.; Van Maele, B.; Engelborghs, Y.; Debyser, Z. // Current Medicinal Chemistry - Anti-Infective Agents;Apr2005, Vol. 4 Issue 2, p153 

    Current strategies for the treatment of human immunodeficiency virus (HIV) infection are based on cocktails of drugs that target the viral entry step and the enzymes reverse transcriptase or protease. At present, the clinical benefit of this combination therapy for HIV-infected patients is...

  • In vitro Activity of Stampidine against Primary Clinical Human Immunodeficiency Virus Isolates. Uckun, Fatih M.; Pendergrass, Sharon; Qazi, Sanjive; Venkatachalam, Taracad K. // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Jan2004, Vol. 54 Issue 1, p69 

    The in vitro activity profile of stampidine (CAS 217178-62-6, STAMP) was examined against clinical isolates of HIV-1. In a side-by-side comparison against 10 zidovudine-sensitive clinical HIV-1 isolates, STAMP was 100-fold more potent than stavudine (CAS 3056-17-5) and twice as effective as...

  • Inhibition of RNA Virus Infections with Peptide-Conjugated Morpholino Oligomers. Stein, David A. // Current Pharmaceutical Design;Sep2008, Vol. 14 Issue 25, p2619 

    RNA virus infections cause immense human disease burdens globally, and few effective antiviral drugs are available for their treatment. Peptide-conjugated phosphorodiamidate morpholino oligomers (PPMO) are nuclease resistant and water-soluble single-stranded-DNA-analogues that can enter cells...

  • A new paradigm in viral resistance. Ruiz, Autumn; Russell, Stephen J // Cell Research;Nov2012, Vol. 22 Issue 11, p1515 

    The rapid mutation of RNA viruses allows for the acquisition of resistance to drugs directly targeting viral proteins. Therefore, a novel approach to the development of antivirals centers on targeting host factors critical to viral replication. A recent report has brought to light the potential...

  • Caught in translation: innate restriction of HIV mRNA translation by a schlafen family protein. Jakobsen, Martin R; Mogensen, Trine H; Paludan, Søren R // Cell Research;Mar2013, Vol. 23 Issue 3, p320 

    Human immunodeficiency virus type 1 (HIV-1) is the cause of AIDS. In recent years it has emerged that cellular interferon-stimulated genes (ISG), play important roles in cell-intrinsic restriction of HIV replication. A publication now describes a novel strategy employed by HIV-infected cells to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics